February 12, 2026

Invitation to presentation of the year-end report 2025

Oncopeptides AB published the report for the fourth quarter and the 2025 year-end report, at 08:00 CET on February 19, 2026. Investors, financial analysts, and media were invited to participate in a webcast and a subsequent Q&A session on February 19 at 09:00 CET.

The webcast was hosted by Sofia Heigis, CEO, together with Henrik Bergentoft, CFO. It was held in English. The presentation as PDF is published below. The webcast was recorded and can be viewed via the link below.

Webcast for investors

https://oncopeptides.events.inderes.com/q4-report-2025

Webcast presentation as PDF